HLA-C and Autoimmunity: We theorize that LoHLAD increases the risk for autoimmunity by limiting the diversity of the MHC–peptide repertoire and thus restricting antigen-specific immune responses; in animal models, restriction of the MHC–peptide repertoire has been shown to predispose to autoimmunity [7].